Linked Life Data

8823339

Source:http://linkedlifedata.com/resource/pubmed/id/8823339

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8823339rdf:typepubmed:Citationlld:pubmed
pubmed-article:8823339lifeskim:mentionsumls-concept:C0032854lld:lifeskim
pubmed-article:8823339lifeskim:mentionsumls-concept:C0278493lld:lifeskim
pubmed-article:8823339lifeskim:mentionsumls-concept:C0034804lld:lifeskim
pubmed-article:8823339lifeskim:mentionsumls-concept:C0279025lld:lifeskim
pubmed-article:8823339lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:8823339lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:8823339lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:8823339lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:8823339lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:8823339lifeskim:mentionsumls-concept:C1561558lld:lifeskim
pubmed-article:8823339lifeskim:mentionsumls-concept:C1517945lld:lifeskim
pubmed-article:8823339pubmed:issue9lld:pubmed
pubmed-article:8823339pubmed:dateCreated1996-10-30lld:pubmed
pubmed-article:8823339pubmed:abstractTextUp to 30% to 40% of metastases from hormone receptor-positive primary breast cancer do not respond to endocrine therapy. We studied how often hormone receptor status changes between primary and recurrent tumors and whether such a change might explain unresponsiveness to endocrine therapy.lld:pubmed
pubmed-article:8823339pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8823339pubmed:languageenglld:pubmed
pubmed-article:8823339pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8823339pubmed:citationSubsetIMlld:pubmed
pubmed-article:8823339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8823339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8823339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8823339pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8823339pubmed:statusMEDLINElld:pubmed
pubmed-article:8823339pubmed:monthSeplld:pubmed
pubmed-article:8823339pubmed:issn0732-183Xlld:pubmed
pubmed-article:8823339pubmed:authorpubmed-author:HolmeTTlld:pubmed
pubmed-article:8823339pubmed:authorpubmed-author:HelinHHlld:pubmed
pubmed-article:8823339pubmed:authorpubmed-author:KononenJJlld:pubmed
pubmed-article:8823339pubmed:authorpubmed-author:IsolaJJlld:pubmed
pubmed-article:8823339pubmed:authorpubmed-author:KuukasjärviTTlld:pubmed
pubmed-article:8823339pubmed:issnTypePrintlld:pubmed
pubmed-article:8823339pubmed:volume14lld:pubmed
pubmed-article:8823339pubmed:ownerNLMlld:pubmed
pubmed-article:8823339pubmed:authorsCompleteYlld:pubmed
pubmed-article:8823339pubmed:pagination2584-9lld:pubmed
pubmed-article:8823339pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8823339pubmed:meshHeadingpubmed-meshheading:8823339-...lld:pubmed
pubmed-article:8823339pubmed:meshHeadingpubmed-meshheading:8823339-...lld:pubmed
pubmed-article:8823339pubmed:meshHeadingpubmed-meshheading:8823339-...lld:pubmed
pubmed-article:8823339pubmed:meshHeadingpubmed-meshheading:8823339-...lld:pubmed
pubmed-article:8823339pubmed:meshHeadingpubmed-meshheading:8823339-...lld:pubmed
pubmed-article:8823339pubmed:meshHeadingpubmed-meshheading:8823339-...lld:pubmed
pubmed-article:8823339pubmed:meshHeadingpubmed-meshheading:8823339-...lld:pubmed
pubmed-article:8823339pubmed:meshHeadingpubmed-meshheading:8823339-...lld:pubmed
pubmed-article:8823339pubmed:meshHeadingpubmed-meshheading:8823339-...lld:pubmed
pubmed-article:8823339pubmed:meshHeadingpubmed-meshheading:8823339-...lld:pubmed
pubmed-article:8823339pubmed:meshHeadingpubmed-meshheading:8823339-...lld:pubmed
pubmed-article:8823339pubmed:meshHeadingpubmed-meshheading:8823339-...lld:pubmed
pubmed-article:8823339pubmed:meshHeadingpubmed-meshheading:8823339-...lld:pubmed
pubmed-article:8823339pubmed:meshHeadingpubmed-meshheading:8823339-...lld:pubmed
pubmed-article:8823339pubmed:meshHeadingpubmed-meshheading:8823339-...lld:pubmed
pubmed-article:8823339pubmed:meshHeadingpubmed-meshheading:8823339-...lld:pubmed
pubmed-article:8823339pubmed:meshHeadingpubmed-meshheading:8823339-...lld:pubmed
pubmed-article:8823339pubmed:year1996lld:pubmed
pubmed-article:8823339pubmed:articleTitleLoss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy.lld:pubmed
pubmed-article:8823339pubmed:affiliationDepartment of Pathology, Tampere University Hospital, University of Tampere, Finland. bltuku@uta.ftlld:pubmed
pubmed-article:8823339pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8823339pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8823339lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8823339lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8823339lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8823339lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8823339lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8823339lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8823339lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8823339lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8823339lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8823339lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8823339lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8823339lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8823339lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8823339lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8823339lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8823339lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8823339lld:pubmed